White Pine Capital LLC Has $587,000 Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)

White Pine Capital LLC raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 189.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,033 shares of the medical instruments supplier’s stock after acquiring an additional 41,925 shares during the quarter. White Pine Capital LLC owned about 0.16% of AngioDynamics worth $587,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its position in AngioDynamics by 110.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 159,391 shares of the medical instruments supplier’s stock valued at $1,240,000 after acquiring an additional 83,622 shares in the last quarter. State Street Corp grew its position in shares of AngioDynamics by 2.7% during the 3rd quarter. State Street Corp now owns 810,372 shares of the medical instruments supplier’s stock worth $6,305,000 after buying an additional 21,218 shares during the period. Barclays PLC grew its position in shares of AngioDynamics by 81.0% during the 3rd quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier’s stock worth $651,000 after buying an additional 37,394 shares during the period. JPMorgan Chase & Co. grew its position in shares of AngioDynamics by 28.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier’s stock worth $4,304,000 after buying an additional 123,271 shares during the period. Finally, CWM LLC grew its position in shares of AngioDynamics by 981.3% during the 3rd quarter. CWM LLC now owns 9,732 shares of the medical instruments supplier’s stock worth $76,000 after buying an additional 8,832 shares during the period. Institutional investors and hedge funds own 89.43% of the company’s stock.

AngioDynamics Stock Up 0.8 %

AngioDynamics stock opened at $10.53 on Friday. The stock has a market capitalization of $426.11 million, a PE ratio of -1.87 and a beta of 0.60. AngioDynamics, Inc. has a twelve month low of $5.26 and a twelve month high of $13.50. The company has a 50 day moving average of $10.42 and a 200-day moving average of $8.30.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The company had revenue of $72.90 million during the quarter, compared to analysts’ expectations of $70.93 million. During the same quarter in the prior year, the company earned ($0.05) earnings per share. The business’s quarterly revenue was down .1% compared to the same quarter last year. Equities analysts anticipate that AngioDynamics, Inc. will post -0.37 EPS for the current fiscal year.

Insider Buying and Selling

In related news, SVP Warren Nighan, Jr. sold 4,060 shares of the stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $12.31, for a total transaction of $49,978.60. Following the completion of the transaction, the senior vice president now owns 41,817 shares in the company, valued at approximately $514,767.27. This represents a 8.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 5.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright boosted their price objective on shares of AngioDynamics from $14.00 to $15.00 and gave the company a “buy” rating in a report on Friday, January 10th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.